Updated December 8 at 6:08pm
Life Sciences
81 results total, viewing 1 - 10
Companies that remove snow, supply electricity to commercial customers and remove toxins from drinking water were among the 30 local enterprises that were recognized Wednesday night at Providence Business News’ fifth Fastest-Growing & Innovative Companies event, held at the Crowne Plaza Providence-Warwick. more
EpiVax Inc. has received a $600,000 grant from the National Institutes of Health through the Small Business Innovation Research program to improve a vaccine for the H7N9 avian influenza virus. more
A Providence-based national advocacy organization for mental illness research, Cure Alliance for Mental Illness, with support from the Brown Institute for Brain Sciences and the Norman Prince Neurosciences Institute, will host Rhode Island’s first-ever Brain Week, March 12-19. more
MindImmune Therapeutics Inc. will receive $500,000 in seed funding from Slater Technology Fund to support the drug discovery venture’s launch. more
BIOTECHNOLOGY Health care is an innovative industry, but Ximedica knows it takes more than a great idea to make a difference. For more than 30 years, this Providence-based company has collaborated with creative thinkers, … more
Six Rhode Island companies have received state matching grants to leverage federal funds intended to promote innovation in technology. more
Nabsys, a genomics firm, recently completed a project generating the world’s first long-range, non-optical maps of entire human genomes. more
Four years ago, MedMates was conceived at a brainstorming session about making economic growth happen in Rhode Island. David Goldsmith, co-founder of the group focused on providing a voice and opportunities for businesses in the state's … more
Kelly Nevins is the first full-time executive director of MedMates, Rhode Island’s health care technology network group. She spoke recently with PBN about its short- and long-term goals and her role with the organization. more
EpiVax Inc., the Rhode Island-based vaccine designer and maker of protein therapeutics, has formed a joint venture with Schroedinger LLC, a leading computational chemistry provider, to design “biosuperior” therapies to treat a range of diseases. more
1 | 2 | 3 | 4 | 5 | 6 | 7 9 | Next »